Intra-anal nifedipine: Phase III started

RDD Pharma began a double-blind, placebo-controlled, European Phase III trial to evaluate 12

Read the full 138 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE